Marc Samuels Shares Insight on Important 2024 Regulatory Decisions with Pharma’s Almanac

Cell and Gene Inflation Reduction Act Oncology/biologics Pharmaceuticals and Biotech Federal And State Policy

December 15, 2023

In this Pharma's Almanac article, ADVI’s Marc Samuels, CEO and president, shares his insights on the most significant regulatory decisions stakeholders should consider as we look ahead to 2024.

On December 15, 2023, in this Pharma’s Almanac article, ADVI Health’s CEO and president, Marc Samuels, shares his insights on the most significant regulatory decisions stakeholders should consider as we look ahead to 2024.

Read more about Marc’s insights and industry predictions for 2024.

Reach out

Own your edge

We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.

Start now.